Safety Study to Determine the Appropriate Dose of Antibody Against Tumor Cells to Best Target Patients With Pancreatic Cancer.
Clinical trial NCT00364364 · TERMINATED
Trial details
- NCT number
- NCT00364364
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2008-08-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.